IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,158,948 | -9.8% | 25,550 | -18.4% | 0.14% | +47.4% |
| Q2 2023 | $1,284,239 | +12.9% | 31,300 | -1.6% | 0.10% | +6.6% |
| Q1 2023 | $1,137,426 | +55738.3% | 31,825 | -41.0% | 0.09% | -47.4% |
| Q4 2022 | $2,037 | -99.9% | 53,925 | -38.6% | 0.17% | -52.5% |
| Q3 2022 | $3,888,000 | +12.4% | 87,895 | -5.9% | 0.36% | +15.2% |
| Q2 2022 | $3,459,000 | -5.7% | 93,445 | -5.6% | 0.32% | +5.7% |
| Q1 2022 | $3,668,000 | +190.4% | 99,020 | +138.5% | 0.30% | +193.1% |
| Q4 2021 | $1,263,000 | +287.4% | 41,520 | +326.9% | 0.10% | +251.7% |
| Q3 2021 | $326,000 | – | 9,725 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |